Literature DB >> 31395385

ADPKD cell proliferation and Cl--dependent fluid secretion.

Gail A Reif1, Darren P Wallace2.   

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is a common genetic disorder characterized by bilateral fluid-filled cysts, renal inflammation and extensive fibrosis, leading to the progressive decline in kidney function. Renal cyst formation begins in utero from aberrant proliferation of tubule epithelial cells; however, the mechanisms for cystogenesis remain unclear. Cell proliferation and Cl--dependent fluid secretion, which drives the accumulation of cyst fluid, are responsible for inexorable growth of cysts and the remarkable appearance of massively enlarged ADPKD kidneys. Investigators have used in vitro assays to explore cellular and molecular mechanisms involved in ADPKD cyst epithelial cell proliferation and Cl--dependent fluid secretion in experimentally controlled environments. These assays have been used to evaluate potential therapeutic approaches to inhibit cellular pathways involved in cyst growth. This chapter discusses methods for measuring ADPKD cell proliferation, transepithelial Cl- secretion, and net fluid transport across cyst epithelial cell monolayers.
© 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anion secretion; Autosomal dominant polycystic kidney disease; Cyst growth; In vitro models; Ion transport

Mesh:

Substances:

Year:  2019        PMID: 31395385     DOI: 10.1016/bs.mcb.2019.06.001

Source DB:  PubMed          Journal:  Methods Cell Biol        ISSN: 0091-679X            Impact factor:   1.441


  6 in total

1.  Passive Diffusion vs Active pH-Dependent Encapsulation of Tyrosine Kinase Inhibitors Vandetanib and Lenvatinib into Folate-Targeted Ferritin Delivery System.

Authors:  Zuzana Skubalova; Simona Rex; Martina Sukupova; Martin Zahalka; Petr Skladal; Jan Pribyl; Hana Michalkova; Akila Weerasekera; Vojtech Adam; Zbynek Heger
Journal:  Int J Nanomedicine       Date:  2021-01-06

2.  Ciclopirox olamine induces ferritinophagy and reduces cyst burden in polycystic kidney disease.

Authors:  Priyanka S Radadiya; Mackenzie M Thornton; Rajni V Puri; Sireesha Yerrathota; Johnny Dinh-Phan; Brenda Magenheimer; Dharmalingam Subramaniam; Pamela V Tran; Hao Zhu; Subhashini Bolisetty; James P Calvet; Darren P Wallace; Madhulika Sharma
Journal:  JCI Insight       Date:  2021-03-30

3.  Quinomycin A reduces cyst progression in polycystic kidney disease.

Authors:  Priyanka S Radadiya; Mackenzie M Thornton; Emily A Daniel; Jessica Y Idowu; Wei Wang; Brenda Magenheimer; Dharmalingam Subramaniam; Pamela V Tran; James P Calvet; Darren P Wallace; Madhulika Sharma
Journal:  FASEB J       Date:  2021-05       Impact factor: 5.191

4.  Overexpression of DJ-1 alleviates autosomal dominant polycystic kidney disease by regulating cell proliferation, apoptosis, and mitochondrial metabolism in vitro and in vivo.

Authors:  Zhongxin Li; Jingjing Zhou; Yan Li; Fan Yang; Xiaoying Lian; Wenhu Liu
Journal:  Ann Transl Med       Date:  2020-09

5.  A cAMP signalosome in primary cilia drives gene expression and kidney cyst formation.

Authors:  Jan N Hansen; Fabian Kaiser; Philipp Leyendecker; Birthe Stüven; Jens-Henning Krause; Fatemeh Derakhshandeh; Jaazba Irfan; Tommy J Sroka; Kenley M Preval; Paurav B Desai; Michael Kraut; Heidi Theis; Anna-Dorothee Drews; Elena De-Domenico; Kristian Händler; Gregory J Pazour; David J P Henderson; David U Mick; Dagmar Wachten
Journal:  EMBO Rep       Date:  2022-06-13       Impact factor: 9.071

6.  The lonidamine derivative H2-gamendazole reduces cyst formation in polycystic kidney disease.

Authors:  Shirin V Sundar; Julie Xia Zhou; Brenda S Magenheimer; Gail A Reif; Darren P Wallace; Gunda I Georg; Sudhakar R Jakkaraj; Joseph S Tash; Alan S L Yu; Xiaogang Li; James P Calvet
Journal:  Am J Physiol Renal Physiol       Date:  2022-08-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.